Severe pulmonary toxicity in patients with leiomyosarcoma after treatment with gemcitabine and docetaxel

被引：5
作者：
Veltkamp, Stephan A.
Terwogt, Jetske M. Meerum
van den Heuvel, Michel M.
van Boven, Hester H.
Schellens, Jan H. M.
Rodenhuis, Sjoerd
机构：
[1] Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, Div Expt Therapy, NL-1066 CX Amsterdam, Netherlands
[2] Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Med Oncol, NL-1066 CX Amsterdam, Netherlands
[3] Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, Dept Pathol, NL-1066 CX Amsterdam, Netherlands
[4] Univ Utrecht, Fac Pharmaceut Sci, Div Biomed Anal, NL-3584 CG Utrecht, Netherlands
来源：
INVESTIGATIONAL NEW DRUGS | 2007年 / 25卷 / 03期
关键词：
pulmonary toxicity; gemcitabine; docetaxel; leiomyosarcoma;
D O I：
10.1007/s10637-006-9030-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：279 / 281
页数：3
相关论文
共 6 条
  • [1] Docetaxel and gemcitabine combination in 133 advanced soft-tissue sarcomas: A retrospective analysis
    Bay, Jacques-Olivier
    Ray-Coquard, Isabelle
    Fayette, Jerome
    Leyvraz, Serge
    Cherix, Stephane
    Piperno-Neumann, Sophie
    Chevreau, Christine
    Isambert, Nicolas
    Brain, Etienne
    Emile, Georges
    Le Cesne, Axel
    Cioffi, Angela
    Kwiatkowski, Fabrice
    Coindre, Jean-Michel
    Bui, Nguyon Binh
    Peyrade, Frederic
    Blay, Jean-Yves
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2006, 119 (03) : 706 - 711
  • [2] Clinical features and correlates of gemcitabine-associated lung injury - Findings from the RADAR project
    Belknap, SM
    Kuzel, TM
    Yarnold, PR
    Slimack, N
    Lyons, EA
    Raisch, DW
    Bennett, CL
    [J]. CANCER, 2006, 106 (09) : 2051 - 2057
  • [3] Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: Results of a phase II trial
    Hensley, ML
    Maki, R
    Venkatraman, E
    Geller, G
    Lovegren, M
    Aghajanian, C
    Sabbatini, P
    Tong, W
    Barakat, R
    Spriggs, DR
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (12) : 2824 - 2831
  • [4] High incidence of pulmonary toxicity of weekly docetaxel and gemcitabine in patients with non-small cell lung cancer: results of a dose-finding study
    Kouroussis, C
    Mavroudis, D
    Kakolyris, S
    Voloudaki, A
    Kalbakis, K
    Souglakos, J
    Agelaki, S
    Malas, K
    Bozionelou, V
    Georgoulias, V
    [J]. LUNG CANCER, 2004, 44 (03) : 363 - 368
  • [5] Laboratory and clinical evidence of synergistic cytotoxicity of sequential treament with gemcitabine followed by docetaxel in the treatment of sarcoma
    Leu, KM
    Ostruszka, LJ
    Shewach, D
    Zalupski, M
    Sondak, V
    Biermann, JS
    Lee, JSJ
    Couwlier, C
    Palazzolo, K
    Baker, LH
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (09) : 1706 - 1712
  • [6] SCOTROC 2A: Carboplatin followed by docetaxel or docetaxel gemcitabine as first-line chemotherapy for ovarian cancer
    Vasey, PA
    Atkinson, R
    Osborne, R
    Parkin, D
    Symonds, R
    Paul, J
    Lewsley, L
    Coleman, R
    Reed, NS
    Kaye, S
    Rustin, GJS
    [J]. BRITISH JOURNAL OF CANCER, 2006, 94 (01) : 62 - 68
1